These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17262707)

  • 41. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
    Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
    Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression.
    Tarasuk M; Songprakhon P; Chimma P; Sratongno P; Na-Bangchang K; Yenchitsomanus PT
    Virus Res; 2017 Aug; 240():180-189. PubMed ID: 28864423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel concept on antiviral strategies to dengue.
    Lo YC; Perng GC
    Curr Opin Virol; 2016 Jun; 18():97-108. PubMed ID: 27284691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes.
    Diwaker D; Mishra KP; Ganju L; Singh SB
    Arch Virol; 2014 Aug; 159(8):1975-86. PubMed ID: 24590566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tree Shrew as a New Animal Model for the Study of Dengue Virus.
    Jiang L; Lu C; Sun Q
    Front Immunol; 2021; 12():621164. PubMed ID: 33841402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and Function of the Non-Structural Protein of Dengue Virus and its Applications in Antiviral Therapy.
    Xie Q; Zhang B; Yu J; Wu Q; Yang F; Cao H; Zhao W
    Curr Top Med Chem; 2017; 17(3):371-380. PubMed ID: 27572085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S; Paci M
    FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.
    Laoprasopwattana K; Libraty DH; Endy TP; Nisalak A; Chunsuttiwat S; Vaughn DW; Reed G; Ennis FA; Rothman AL; Green S
    J Infect Dis; 2005 Aug; 192(3):510-9. PubMed ID: 15995967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.
    Simmons M; Putnak R; Sun P; Burgess T; Marasco WA
    Am J Trop Med Hyg; 2016 Nov; 95(5):1148-1156. PubMed ID: 27645784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients.
    Nguyen NM; Tran CN; Phung LK; Duong KT; Huynh Hle A; Farrar J; Nguyen QT; Tran HT; Nguyen CV; Merson L; Hoang LT; Hibberd ML; Aw PP; Wilm A; Nagarajan N; Nguyen DT; Pham MP; Nguyen TT; Javanbakht H; Klumpp K; Hammond J; Petric R; Wolbers M; Nguyen CT; Simmons CP
    J Infect Dis; 2013 May; 207(9):1442-50. PubMed ID: 22807519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
    Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
    Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2.
    Martinez-Gutierrez M; Correa-Londoño LA; Castellanos JE; Gallego-Gómez JC; Osorio JE
    PLoS One; 2014; 9(2):e87412. PubMed ID: 24586275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.
    Miller JL; Lachica R; Sayce AC; Williams JP; Bapat M; Dwek R; Beatty PR; Harris E; Zitzmann N
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6379-86. PubMed ID: 23070155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial.
    Tam DT; Ngoc TV; Tien NT; Kieu NT; Thuy TT; Thanh LT; Tam CT; Truong NT; Dung NT; Qui PT; Hien TT; Farrar JJ; Simmons CP; Wolbers M; Wills BA
    Clin Infect Dis; 2012 Nov; 55(9):1216-24. PubMed ID: 22865871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease.
    Sierra B; Magalhães AC; Soares D; Cavadas B; Perez AB; Alvarez M; Aguirre E; Bracho C; Pereira L; Guzman MG
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions.
    Whitehorn J; Yacoub S; Anders KL; Macareo LR; Cassetti MC; Nguyen Van VC; Shi PY; Wills B; Simmons CP
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3025. PubMed ID: 25166493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chloroquine use improves dengue-related symptoms.
    Borges MC; Castro LA; Fonseca BA
    Mem Inst Oswaldo Cruz; 2013 Aug; 108(5):596-9. PubMed ID: 23903975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uptake and metabolism of BuCast: a glycoprotein processing inhibitor and a potential anti-HIV drug.
    Kang MS
    Glycobiology; 1996 Mar; 6(2):209-16. PubMed ID: 8727792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.